CSIMarket


Catalent Inc   (CTLT)
Other Ticker:  
 

Catalent Inc

CTLT's Fundamental analysis








Catalent Inc 's sales fell by -13.99 % in I. Quarter 2022 from the same quarter a year ago. Ranking at No. 1217

Major Pharmaceutical Preparations industry recorded growth of revenues by 0.81 %



More on CTLT's Growth


Catalent Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company
PE TTM   
Industry
0.01
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.82.


More on CTLT's Valuation
 
 Total Debt (Millions $) 4,204
 Dividend TTM ($) 0.02 $
 Dividend Yield TTM (%) 0.04 %
 Revenue/Employee (TTM) $ 345,086
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.05
 Tangible Book Value (Per Share $)

Catalent Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company
PE TTM   
Industry
0.01
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.82.